Issue 9, 2020

Antileishmanial assessment of isoxazole derivatives against L. donovani

Abstract

A chemical library comprising substituted 3-nitroisoxazoles and 3-aminoisoxazoles was prepared and screened for their antileishmanial activity against L. donovani. As compared to Miltefosine, the standard drug used in bioassays, several compounds displayed remarkably better inhibition of the promastigote and amastigote stages of parasites. The in vivo evaluation of a few compounds in a golden hamster model showed significant reduction of the parasite load post treatment via the intraperitoneal route by several compounds. The preliminary pharmacokinetic evaluation of a representative compound 4mfvia the oral route, however, indicated high systemic clearance from the body.

Graphical abstract: Antileishmanial assessment of isoxazole derivatives against L. donovani

Supplementary files

Article information

Article type
Research Article
Submitted
09 Mar 2020
Accepted
23 Jun 2020
First published
20 Jul 2020

RSC Med. Chem., 2020,11, 1053-1062

Antileishmanial assessment of isoxazole derivatives against L. donovani

S. Mukhopadhyay, D. S. Barak, R. Karthik, S. K. Verma, R. S. Bhatta, N. Goyal and S. Batra, RSC Med. Chem., 2020, 11, 1053 DOI: 10.1039/D0MD00083C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements